- Home
- WMK vs IMTX Comparison
WMK vs IMTX Comparison
Compare WMK & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WMK | IMTX |
|---|---|---|
| Founded | 1912 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WMK | IMTX |
|---|---|---|
| Price | $67.94 | $9.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $19.25 |
| AVG Volume (30 Days) | 122.1K | ★ 591.1K |
| Earning Date | 11-04-2025 | 11-17-2025 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | ★ 6.99 | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | ★ $4,894,832,000.00 | $99,445,031.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.39 |
| P/E Ratio | $17.92 | ★ N/A |
| Revenue Growth | ★ 2.20 | N/A |
| 52 Week Low | $61.53 | $3.30 |
| 52 Week High | $90.23 | $12.41 |
Technical Indicators
Market Signals| Indicator | WMK | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 44.86 |
| Support Level | $65.49 | $9.85 |
| Resistance Level | $68.37 | $10.24 |
| Average True Range (ATR) | 1.70 | 0.67 |
| MACD | 0.23 | -0.11 |
| Stochastic Oscillator | 86.75 | 2.78 |
Price Performance
Historical ComparisonAbout WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.